PCM
HIMS icon

Portolan Capital Management’s Hims & Hers Health HIMS Stock Holding History

Portolan Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-932,652
Closed -$8.3M – 133
2023
Q4 		$8.3M Buy
932,652
+782,652
+522% +$5.79M 0.73% 46
2023
Q3 		$944K Buy
+150,000
New +$1.12M 0.09% 118

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Portolan Capital Management's HIMS Position: Q1 2024 in Review

Portolan Capital Management sold out of Hims & Hers Health (HIMS) in Q1 2024, closing a stake of 932,652 shares — an estimated $8.3M sold.

Portolan Capital Management first reported a position in HIMS in Q3 2023 and held it in 2 quarters. The position peaked at $8.3M in Q4 2023. 244 funds tracked by Wall St. Rank hold HIMS as of Q1 2024.

  • Portolan Capital Management reported no remaining Hims & Hers Health position as of Q1 2024 after selling out during the quarter.
  • Portolan Capital Management sold 932,652 Hims & Hers Health shares in Q1 2024, an estimated $8.3M.
  • Portolan Capital Management first reported a position in Hims & Hers Health in Q3 2023 and held it in 2 quarters.
  • Portolan Capital Management's Hims & Hers Health position peaked at $8.3M in Q4 2023.
  • 244 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2024.

Based on Portolan Capital Management's 13F filing for Q1 2024, filed 15 May 2024.